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Abstract
 
The cytokine potential of developing T helper (Th) cells is directly shaped both positively and
negatively by the cytokines expressed by the effector Th cell subsets. Here we find that the re-
cently identified cytokine, interleukin (IL)-21, is preferentially expressed by Th2 cells when
compared with Th1 cells generated in vitro and in vivo. Exposure of naive Th precursors to
IL-21 inhibits interferon (IFN)-
 
 
 
 production from developing Th1 cells. The repression of
IFN-
 
 
 
 production is specific in that the expression of other Th1 and Th2 cytokines is unaffected.
IL-21 decreases the IL-12 responsiveness of developing Th cells by specifically reducing both
signal transducer and activator of transcription 4 protein and mRNA expression. These results
suggest that Th2 cell-derived IL-21 regulates the development of IFN-
 
 
 
–producing Th1 cells
which could serve to amplify a Th2 response.
Key words: cytokines • T lymphocytes helper inducer • cell differentiation • 
immunosuppression • interleukins
 
Introduction
 
Th subsets are distinguished by their ability to produce dis-
tinct cytokine patterns and promote specific immune
responses (1–3). Th1 cells produce IFN-
 
 
 
 and promote cell–
mediated immunity directed toward intracellular patho-
gens. In contrast, Th2 cells produce cytokines such as IL-4,
IL-5, and IL-13, activate mast cells and eosinophils, and di-
rect B cell responses against extracellular pathogens. Dys-
regulation of Th cell responses can result in immunopa-
thology in that aberrant Th1 responses can be responsible
for organ-specific autoimmunity and exaggerated Th2 re-
sponses have been associated with allergic diseases. Conse-
quently, understanding the regulation of balanced Th cell
immune responses has been an area of intense investigation
in recent years.
The specific cytokines produced by polarized Th1 and
Th2 cells are the primary effectors that promote the differ-
entiation of precursor Th cells, but these cytokines also
cross-regulate the other subset’s functional activity (3). For
example, IL-4 is the most potent factor described to pro-
mote the differentiation of Th precursor (Thp)
 
*
 
 cells to
Th2 effectors but IL-4 also antagonizes the production of
IFN-
 
 
 
 by Th1 cells (4). IL-10, another cytokine produced
by Th2 cells, has also been described to inhibit Th1 devel-
opment and IFN-
 
 
 
–induced macrophage function (5).
Conversely, the IFN-
 
 
 
–produced by Th1 cells amplifies
Th1 development and inhibits the expansion of Th2 cells
(4, 6). The ability of these cytokines to promote the devel-
opment of specific Th cell subsets while simultaneously in-
hibiting the alternate developmental fate results in a pro-
gressively polarized immune response.
IL-21 is a recently described cytokine produced by acti-
vated CD4
 
 
 
 T cells that is capable of costimulating T and
B cell proliferation and regulating natural killer (NK) cell
activation and expansion (7, 8). IL-21 shares sequence ho-
mology with the cytokines IL-2, IL-15, and IL-4 and me-
diates its effects through a novel class I cytokine receptor,
IL-21R, associated with the common 
 
 
 
 cytokine receptor
chain (7–9). IL-21R, which is similar to the IL-2/IL-15R
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chain and IL-4R 
 
 
 
 chain, is widely expressed among lym-
phoid tissues (7, 10). Although IL-21 was shown to be
expressed exclusively by CD4
 
 
 
 T cells, the expression of
IL-21 within Th cell subsets has not been reported (7). Ad-
ditionally, the potential role of IL-21 in Th cell differentia-
tion has not been explored.
In this report, we demonstrate that IL-21 is preferentially
expressed in Th2 cells generated in vitro and in vivo. Ex-
posure of differentiating Th cells to IL-21 specifically in-
hibits the production of IFN-
 
 
 
 but not other Th1 cyto-
kines such as IL-2 or TNF-
 
 
 
. IL-21 treatment reduces the
ability of developing Th cells to respond to IL-12 by de-
creasing the total amount of cellular signal transducer and
activator of transcription (STAT)-4 resulting in diminished
IFN-
 
 
 
 production by Th1 cells. These findings suggest that
IL-21 is a cytokine produced by previously derived Th2 ef-
fector cells that serves to modulate the development of
IFN-
 
 
 
–producing Th1 cells and consequently amplify a
Th2 response.
 
Materials and Methods
 
Mice.
 
Unless indicated otherwise, C57BL/6 mice of 6–8 wk
of age were used in all experiments. STAT-6–deficient mice on
C57BL/6 background were generated as described previously
(11). IL-21R–deficient mice backcrossed on the C57BL/6 back-
ground were generated as described previously (12).
 
Lymphocyte Preparation and Culture.
 
Lymphocytes were cul-
tured in RPMI 1640 supplemented as described previously (11).
Naive Thp cells were purified from lymph node and spleens by
cell sorting using anti-CD4 and anti-CD62L (BD PharMingen)
to 95–98% purity.
 
Antibodies and Cytokines.
 
T-bet–specific antiserum was a gift
from L. Glimcher and S. Szabo, Harvard School of Public Health,
Boston, MA (13). Antibodies specific for STAT-4, STAT-1, and
actin were obtained from Santa Cruz Biotechnology, Inc. Anti-
body specific for phosphorylated STAT-4 was obtained from
Zymed Laboratories. The antibodies to anti-CD3, anti-CD28,
IL-4, and IFN-
 
 
 
 used in Th cell differentiation cultures were ob-
tained from BD PharMingen. Recombinant IL-4 was obtained
from Peprotech. Recombinant IL-2 was provided by Chiron.
Recombinant IL-12 was provided by Hoffmann-LaRoche.
Mouse IL-21 expressed in COS cell supernatants was prepared
and concentrated as described previously (12). Mock transfected
COS supernatant, prepared and concentrated in parallel with IL-
21, was used as a control.
 
In Vitro Th Cell Differentiation.
 
Naive Thp cells were plated
onto 1 
 
 
 
g/ml anti-CD3, 2 
 
 
 
g/ml anti-CD28–coated plates at
1–2 
 
 
 
 10
 
6
 
 cells per milliliter in the presence of 10 ng/ml IL-4, 10
 
 
 
g/ml anti–IFN-
 
 
 
 (Th2 conditions), or 1 ng/ml IL-12 and 10
 
 
 
g/ml anti–IL-4 (Th1 conditions). 100 U/ml IL-2 was added
24 h later. Cultures were expanded in 100 U/ml IL-2 3 d after
initial culture. After 1 wk in culture, the cells were stimulated
with PMA/ionomycin and cytokine production was determined
by intracellular cytokine staining as described previously (14).
 
RNA Analysis.
 
Total RNA was isolated using RNeasy
(QIAGEN). For Northern blot analysis the RNA was separated
on a 1.5% agarose/6% formaldehyde gel and transferred to Gene-
Screen (NEN Life BioSciences) membrane. The membrane was
hybridized with radiolabeled cDNA probes for IL-21, IL-4,
IFN-
 
 
 
, and 
 
 
 
-actin. For RealTime PCR, 1 
 
 
 
g of RNA was
primed with oligo (dT) and converted to cDNA using Superscript
(Invitrogen Life Technologies). 1/40th of the resulting cDNA was
used as template in PCR reactions using SYBR Green 2
 
 
 
 or
TaqMan 2
 
 
 
 PCR mix (Applied Biosystems) and analyzed in the
ABI Prism 7700 Sequence Detector (Applied Biosystems) using
the following primers: IL-21 forward 5
 
 
 
 AAGATTCCTGAG-
GATCCGAGAAG 3
 
 
 
; IL-21 reverse 5
 
 
 
 GCATTCGT-
GAGCGTCTATAGTGTC 3
 
 
 
; IL-21 TaqMan probe 5
 
 
 
 TTC-
CCGAGGACTGAGGAGACGCC 3
 
 
 
; IL-12R
 
 
 
2 forward 5
 
 
 
TTTCCATTTTTGCATCAAGTTCTC 3
 
 
 
;
 
 
 
IL-12R
 
 
 
2 reverse
5
 
 
 
 CCGATCTAGAGTCAGCCGCT 3
 
 
 
;
 
 
 
STAT-4 forward 5
 
 
 
AAACCTGAGCCCAACGACAA 3
 
 
 
; STAT-4 reverse 5
 
 
 
AGTGTCCGTTTGCACCGTC 3
 
 
 
. Primers and TaqMan
probes for IL-4, IFN-
 
 
 
,
 
 
 
and GAPDH have been published pre-
viously (15).
 
Immunoblot Analysis.
 
Whole cell extracts were prepared by
lysing cells in 50 mM Tris, 0.5% NP40, 5 mM EDTA, 50 mM
NaCl, and clearing the lysates by centrifugation. Protein extracts
were separated on an 8–10% polyacrylamide gel and transferred
to an Optitran membrane (Schleicher and Schuell). The immu-
noblots were blocked for 1 h at room temperature in 5% milk in
TBST (50 mM Tris, pH 7.5,100 mM NaCl, and 0.03% Tween
20) and incubated with the indicated antibody overnight at 4
 
 
 
C.
The blots were washed with TBST and incubated with anti–rab-
bit HRP-conjugated antibody (Zymed Laboratories) at room
temperature. After washing the blots with TBST, detection was
performed using enhanced chemiluminescence (Amersham Phar-
macia Biotech) according to manufacturer’s instructions.
 
Leishmania Infections.
 
Eight 4–5-wk-old BALB/c and
C57BL/6 mice were infected in the hind right foodpad with 2 
 
 
 
10
 
6
 
 stationary-phase 
 
Leishmania major 
 
promastigotes (LV39) as de-
scribed previously (16).
 
Delayed-type Hypersensitivity Reaction.
 
8-wk-old male mice
were immunized subcutaneously with 100 
 
 
 
g TNP-KLH (Bio-
search Technologies) emulsified in CFA at the tailbase. After 6 d
mice were challenged with 50 
 
 
 
g of TNP-KLH in one hind
footpad and PBS in the contralateral hind footpad. Footpad
thickness was measured 24 h after challenge. Specific swelling
was determined by subtracting nonspecific swelling in the PBS-
injected foot from antigen-induced swelling. Purified CD4
 
 
 
 T
cells from draining lymph nodes were removed and stimulated in
vitro with 250 
 
 
 
g/ml TNP-KLH and irradiated APCs. The re-
sulting supernatants were assessed for IFN-
 
 
 
 production by
ELISA 72 h later.
 
Results
 
IL-21 Is a Th2 Cytokine.
 
Although IL-21 has been re-
ported to have a wide range of effects on a number of cell
types, the only reported source of IL-21 thus far is activated
CD4
 
 
 
 T cells (7). To determine if IL-21 is expressed ex-
clusively within Th cell subsets, Northern blot analysis was
performed on mRNA from naive Thp cells differentiated
into Th1 or Th2 cells for 1 wk and restimulated for 4 h to
induce cytokine production. IL-21 mRNA was undectable
in Th1 cell cultures, but induced in Th2 cells suggesting
that IL-21 is a Th2 cytokine (Fig. 1 A).
IL-21 could be regulated like other Th2 cytokines in that
the potential to produce IL-21 increases as the cells develop
along the Th2 pathway. Alternatively, the preferential ex-
pression of IL-21 in Th2 cells could be due to an extinction 
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of already high IL-21 production in Thp cells as the cells
develop into Th1 effectors. To address this we compared
IL-21 message expression in primary stimulated Thp cells
and secondary stimulated Th2 cells. We found that IL-21
message, like IL-4, is relatively low but detectable in Thp
cells after primary stimulation and is markedly induced after
the cells are allowed to differentiate along the Th2 pathway
(Fig. 1 B). These results suggest that IL-21 gene expression
is regulated similarly to other Th2-specific cytokines.
Next, we determined if IL-21 expression in differenti-
ated cells could be directly affected by the cytokine milieu.
To address this, we cultured Th1 and Th2 cells in the pres-
ence of IL-4 and IFN-
 
 
 
, respectively, before secondary
stimulation. Cells were responsive to these cytokines as ev-
idenced by the activation of STAT-6 and STAT-1 by IL-4
and IFN-
 
 
 
, respectively (unpublished data). We found that
the addition of IL-4 to Th1 cells had no effect on IL-21 ex-
pression (Fig. 1 C). Moreover, the addition of IFN-
 
 
 
 to
the Th2 cultures had no inhibitory effect on the expression
of IL-21. These results suggest that the expression of IL-21
in Th2 cells appears to be fixed early in Th2 differentiation
and not modulated directly by IL-4 or IFN-
 
 
 
.
The experiments described above examined IL-21 ex-
pression during in vitro Th2 differentiation. We wished to
determine if IL-21 expression by Th2 cells is also reflected
during a Th2 immune response in vivo. Infection with the
protozoan 
 
Leishmania major
 
 provides a well characterized
model for studying the in vivo response of Th cells (17).
Inbred mouse strains such as C57BL/6 infected with 
 
L.
major
 
 mount a protective Th1 response against the patho-
gen that provides resistance to the disease. Conversely,
BALB/c mouse strains develop a predominantly Th2 re-
sponse and fail to clear the infection. We infected both
C57BL/6 and BALB/c mice with 
 
L. major
 
 and assessed the
cytokine expression in CD4
 
 
 
 cells purified from draining
lymph nodes from infected animals. As expected, CD4
 
 
 
 T
cells from C57BL/6 infected mice expressed more IFN-
 
 
 
than cells from BALB/c infected mice (Fig. 1 D). Corre-
sponding with a predominantly Th2 response, CD4
 
 
 
 T
cells from infected BALB/c mice made significantly more
IL-4 than T cells from C57BL/6 mice (Fig. 1 D). Similar
to that observed under in vitro Th2 skewing conditions,
IL-21 was also preferentially expressed during an in vivo
Th2 response in BALB/c mice (Fig. 1 D). These results,
Figure 1. IL-21 is a Th2 cytokine. (A) Thp cells were cultured under Th1 and Th2 skewing conditions for
6 d. The cells were left resting ( ) or restimulated with PMA/Ionomycin (P I) for 4 h. Similar results were ob-
served for 6 and 24 h after stimulation (unpublished data). RNA was purified and assessed for cytokine expression
by Northern blot analysis. The results shown are representative of three independent experiments. (B) Thp cells
were cultured under neutral, Th1, and Th2 skewing conditions. RNA was purified 24 h after primary and sec-
ondary anti-CD3 stimulation. Cytokine expression was assessed in duplicate by RealTime PCR and shown rel-
ative to GAPDH. (C) Thp cells were cultured under Th1 and Th2 skewing conditions for 5 d. IL-4 or IFN- 
were added to indicated cultures 24 h before secondary stimulation with anti-CD3. RNA was purified 24 h after
secondary stimulation and IL-21 expression was assessed in duplicate and shown relative to GAPDH by Real-
Time PCR. (D) Cohorts of eight BALB/c and C57BL/6 mice were infected with L. major in hind footpads. Af-
ter 6 wk CD4  T cells from draining lymph nodes were purified and stimulated with anti-CD3. RNA was pu-
rified 6 h after stimulation and cytokine expression was assessed relative to GAPDH by RealTime PCR. 
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combined with our in vitro findings, strongly suggest that
IL-21 is a Th2 cytokine.
 
IL-21 Specifically Inhibits the Production of IFN-
 
 
 
 in Devel-
oping Th Cells.
 
Because IL-21 shares a similar expression
pattern in Th cells as well as structural similarity to IL-4,
we wished to determine if IL-21, like IL-4, could influence
Th cell differentiation directly. To address this, purified na-
ive Thp cells were primed under neutral, Th1 and Th2
skewing conditions in the presence and absence of IL-21.
The cytokine potential of these cells was assessed by intra-
cellular cytokine staining after 1 wk in culture. Like IL-4,
the inclusion of IL-21 to neutral and Th1 cultures resulted
in a marked reduction in the number of IFN-
 
 
 
–producing
cells (neutral and Th1 conditions, Fig. 2 A). The decreased
number of IFN-
 
 
 
–producing cells in Th1 cultures was
confirmed by ELISPOT analysis and observed by restimu-
lating with either PMA/Ionomycin or anti-CD3 (unpub-
lished data). Additionally, the defect in IFN-
 
 
 
 production
in Th1 cultures could not be overcome by the inclusion of
IL-18 (unpublished data). Unlike IL-4, however, IL-21 it-
self was unable to potentiate the production of IL-4–pro-
ducing Th2 cells (neutral conditions, Fig. 2 A). IL-21 treat-
ment also had no stimulating or inhibitory effect on the
generation of IL-4–producing cells under Th2 skewing
conditions (Th2, Fig. 2 A). Inclusion of IL-21 in Th cell
cultures had no detrimental effect on cell viability as as-
sessed by Trypan blue exclusion.
As we observed reduced numbers of IFN-
 
 
 
–producing
Th1 effector cells 1 wk after IL-21 was included in the pri-
mary stimulation, we wished to determine if IL-21 also af-
fected the IFN-
 
 
 
 produced from recently stimulated Thp
cells. To assess this, purified naive Thp cells were cultured
under neutral and Th1 conditions in the presence or ab-
sence of IL-21 for 48 h. The resulting culture supernatants
were assessed for IFN-
 
 
 
 production by ELISA. We found
that IL-21 reduced the amount of IFN-
 
 
 
 produced early in
differentiation cultures (Fig. 2 B). Therefore, the presence
of IL-21 during Th cell priming affects the ability of differ-
entiating Th1 cells to produce IFN-
 
 
 
.
 
IL-21 Does Not Directly Inhibit IFN-
 
 
 
 Production from Th1
Effector Cells.
 
The experiments described above assessed
the effects of IL-21 on the development of IFN-
 
 –produc-
ing cells when included during the initial priming of Thp
cells. This raises the question of whether IL-21 is directly
repressing the production of IFN-  or affecting the differ-
entiation of IFN- –producing Th1 cells. To address this
issue, purified naive Thp cells were cultured under Th1
skewing conditions for 5 d and IL-21 was subsequently
added 24 h before secondary stimulation. Unlike what was
observed when IL-21 was added at the initiation of culture,
the addition of IL-21 to Th1 cultures at the end of the dif-
ferentiation period had no effect on IFN-  production
(Fig. 3 A) even though Th1 cells express IL-21R (unpub-
lished data). This finding suggests that IL-21 impairs the
ability of Thp cells to differentiate into IFN- –producing
Th1 cells but does not directly inhibit IFN-  production
from Th1 effector cells.
IL-21 Inhibition of IFN-  Is Independent of IL-4 Signaling.
IL-4 is known to inhibit the differentiation of Th1 cells and
effects of IL-4 on Th cell differentiation largely depend on
the expression of STAT-6 (11, 18, 19). To determine if
IL-21–mediated inhibition of IFN-  production is medi-
ated indirectly through the action of IL-4 we assessed the
ability of IL-21 to influence Th1 differentiation in STAT-6–
deficient Thp cells. In the absence of STAT-6, IL-21 was
just as effective in preventing the generation of IFN- –
producing cells (Fig. 3 B). These results suggest that the
IL-21 induced repression of IFN-  is not mediated indi-
rectly through the action of IL-4. Additionally, unlike
IL-4, IL-21 does not depend on STAT-6 signaling to pre-
vent the generation of IFN- –producing Th1 cells.
IL-21 Does Not Inhibit Other Th1 Cytokines. The ex-
periments thus far evaluated the ability of IL-21–treated
Th1 cells to produce IFN- . To determine if IL-21 treat-
ment affects other aspects of Th1 development we assessed
the ability of IL-21–treated Thp cells to produce other cy-
tokines preferentially expressed by Th1 cells. Thp cells
were cultured under Th1 skewing conditions in the pres-
Figure 2. Impaired IFN-  production from IL-21–
treated Th cells. (A) Thp cells were cultured under neu-
tral, Th1, and Th2 skewing conditions for 1 wk in the
presence of 20 ng/ml IL-21 or mock supernatants. Cyto-
kine production was assessed by intracellular cytokine
staining 4 h after restimulation with PMA/Ionomycin.
Results are representative of at least 10 experiments. (B) Thp cells were cultured in the presence of 20 ng/ml IL-21 or mock supernatants under neutral
and Th1 conditions for 48 h. Culture supernatants were assessed for IFN-  production by ELISA.973 Wurster et al.
ence and absence of IL-21 and assessed for cytokine pro-
duction by intracellular cytokine staining after secondary
stimulation. Surprisingly, although the number of IFN- –
producing cells is significantly reduced when IL-21 is in-
cluded in the priming conditions, the same cell population
has normal numbers of IL-2 and TNF- –producing cells as
well as normal message levels for LT  (Fig. 3 C and unpub-
lished data). Additionally, IL-21–treated and untreated Th1
cells make similar, high levels of IL-3 and GM-CSF, two
cytokines that are made only by differentiated but not naive
T cells, thus suggesting that IL-21–treated Th1 cells have
differentiated beyond the naive state (unpublished data).
These results imply that although IL-21 efficiently sup-
presses the ability of Th1 cells to produce IFN- , the same
cells maintain the capacity to produce other Th1 cytokines
and do not default to produce Th2 cytokines (Fig. 1).
T-bet Expression Is Unaffected by IL-21. T-bet is a re-
cently identified transcription factor specifically expressed
in differentiating Th1 cells that is capable of potently in-
ducing IFN-  (13). Because of its important role in IFN- 
production in Th1 cells, T-bet is an attractive potential tar-
get for IL-21. To determine if IL-21 treatment of differen-
tiating Th1 cells affects the induction of T-bet expression
in Th1 cells, naive Thp cells were cultured under Th1
skewing conditions in the presence and absence of IL-21
for 48 h. Protein extracts from these cells were analyzed for
T-bet expression by Western blot analysis. As expected,
T-bet expression was induced in Th1 cultures and re-
mained low under Th2 conditions (Fig. 4 A). Addition of
IL-21 had no effect on T-bet expression in Th1 cells. This
result indicates that IL-21–mediated suppression of IFN- 
production is not a result of reduced T-bet expression.
IL-21 Inhibits IL-12 Signaling. IL-12 signaling plays a
critical role in the development of Th1 cells. Th cells lack-
ing IL-12R are severely compromised in their ability to
produce IFN-  (20). Additionally, IL-12R 2 chain ex-
pression is specifically extinguished in developing Th2
cells, an effect mediated by IL-4 (21). To determine if IL-
21, like IL-4, affects the expression of IL-12R 2 chain in
Th1 cells, mRNA from naive Thp cells cultured under
Th1 skewing conditions in the presence and absence of IL-
21 was analyzed for IL-12R 2 expression by RealTime
PCR. As expected, IL-12R 2 expression was high in Th1
cells when compared with Th2 cells. However, addition of
IL-21 to the Th1 cultures did not affect IL-12R 2 expres-
sion (Fig. 4 B). Therefore, unlike that reported for IL-4,
IL-21 treatment did not result in decreased expression of
IL-12R 2. Moreover, the high IL-12R 2 expression cou-
pled with high TNF-  and IL-2 levels suggests that IL-21–
treated Th1 cells maintain many Th1 characteristics with
the distinct exception of decreased IFN-  production.
STAT-4 is specifically activated by IL-12 and is a critical
signaling mediator for the generation of IFN- –producing
Th1 cells (22). To determine if IL-21 affects the ability of
IL-12 to activate STAT-4, naive Thp cells were activated
for 48 h in the presence or absence of IL-21. The cells
were subsequently stimulated with IL-12 and the extent of
STAT-4 phosphorylation was determined by Western blot
analysis. Although IL-21–treated cells express normal levels
of IL-12R 2, STAT-4 phosphorylation in response to IL-
12 stimulation was reduced in IL-21–treated cells (Fig. 4
C). The decreased level of phosphorylated STAT-4 is also
reflected by a decrease in total STAT-4 protein levels (Fig.
4 C). As a comparison, STAT-1 protein expression is unaf-
fected by IL-21 treatment (Fig. 4 C). The IL-21–induced
Figure 3. IL-21 specifically inhibits IFN-  production from develop-
ing Th1 cells. (A) Thp cells were cultured under Th1 skewing conditions.
20 ng/ml IL-21 or mock supernatant was added either at the beginning of
culture (day 0) or 24 h before restimulation and analysis (day 5). Cytokine
production was assessed by intracellular cytokine staining. (B) Thp cells
purified from wild-type or STAT-6–deficient mice were cultured for 1
wk under Th1 skewing conditions in the presence of IL-21 or mock su-
pernatant. Cytokine production was assessed by intracellular cytokine
staining. (C) Thp cells were cultured under Th1 skewing conditions in
the presence of IL-21 or mock supernatant. Cytokine expression was
assessed by intracellular cytokine staining.974 IL-21 and Th Cell Differentiation
decrease in STAT-4 protein levels is likely due to a de-
crease in STAT-4 mRNA (Fig. 4 D). These findings sug-
gest that IL-21 treatment dampens the responsiveness of
developing Th1 cells to IL-12 through a reduction of
STAT-4 expression.
IL-21 Signaling Is Required for Limiting a Th1 Response In
Vivo. Given our observation that IL-21 treatment could
inhibit Th1 cell function in vitro, we wished to determine
if endogenously produced IL-21 plays a role in limiting
Th1 cell function in vivo. To this end, we examined a clas-
sic Th1 cell–mediated inflammatory response, the delayed-
type hypersensitivity (DTH) reaction in IL-21R–deficient
mice. DTH responses to a specific antigen (TNP-KLH)
were examined by injection of antigen or PBS to the hind
footpads of previously immunized wild-type or IL-21R–
deficient mice. Footpad swelling was determined 24 h
later. Wild-type animals responded to antigenic challenge
with robust swelling of the footpad (Fig. 5 A). Interest-
ingly, IL-21R–deficient mice mounted a much stronger
DTH response resulting in an average of twice the swelling
(Fig. 5 A). The increased DTH response in IL-21R–defi-
cient animals correlated with a marked increase in IFN- 
Figure 4. IL-21 inhibits STAT-4 signaling.
(A) Thp cells were cultured under Th1 or Th2
skewing conditions. Protein extracts were har-
vested at the beginning (naive) and 48 h after
culture (Th1 and Th2). During which 20 ng/
ml IL-21 or mock supernatants were included
in the indicated cultures. T-bet and actin ex-
pression were determined by Western blot
analysis. (B) Thp cells were cultured under
Th1 or Th2 skewing conditions for 1 wk. 20
ng/ml IL-21 or mock supernatant was in-
cluded in indicated cultures. RNA was har-
vested 24 h after secondary stimulation with
anti-CD3 and assessed for IL-12R 2 expression
by RealTime PCR. The results are representa-
tive of three independent experiments. (C)
Thp cells were stimulated with anti-CD3 for
48 h in the presence of 20 ng/ml IL-21 or
mock supernatants. The cells were then stimu-
lated for 15 min with 1 ng/ml IL-12. Protein
extracts were assessed for phosphorylated
STAT-4 (p-STAT-4), STAT-4, and STAT-1
by Western blot analysis. Results are represen-
tative of four independent experiments. (D)
Thp cells were cultured as in C. RNA was
harvested and assessed for STAT-4 expression
in duplicateby RealTime PCR and shown rel-
ative to GAPDH. Results are representative of
three independent experiments.
Figure 5. Enhanced DTH responses in IL-21R–deficient mice. (A) Specific footpad swelling of wild-type and IL-21R–deficient (IL-21R / ) mice
was determined by subtracting nonspecific swelling in the PBS-injected footpad from the TNP-KLH-induced swelling. Each data point represents one
mouse and horizontal lines indicate averages. Results are pooled of two independent experiments. (B) Purified CD4  T cells from the draining lymph
nodes of immunized mice were stimulated in vitro with 250  g/ml TNP-KLH and irradiated APCs. Supernatants were analyzed for IFN-  levels by
ELISA. Results shown are the average of two mice from each genotype performed in duplicate.975 Wurster et al.
production from CD4  T cells purified from the draining
lymph nodes and restimulated by antigen in vitro (Fig. 5
B). These results strongly support the notion that IL-21 is
involved in limiting Th1 cell responses by suppressing the
production of IFN- .
Discussion
In this report, we demonstrate that the newly described
cytokine, IL-21, is preferentially expressed in Th2 cells
compared with Th1 cells. We have also shown that IL-21
influences Th cell differentiation by inhibiting the produc-
tion of IFN-  from developing Th1 cells, due to a de-
crease in the effectiveness of IL-12 signaling. The effect on
IFN-  expression is remarkably specific in that other char-
acteristics of Th1 differentiation are intact (T-bet, IL-2,
TNF- , IL-12R 2). Lack of IL-21 signaling in vivo re-
sults in an increased DTH response, characterized by an
increased inflammatory response and antigen-specific
IFN-  production by Th1 cells. Given the specific effect
on IFN-  production, IL-21 expression by previously acti-
vated Th2 cells could serve to bias away from a Th1 re-
sponse and promote the expansion of Th2 cells by specifi-
cally suppressing IFN- .
Although Th2 cells express IL-21, the IL-21 gene is
not genetically linked to the Th2 cytokine gene cluster
that includes IL-4,  IL-5, and IL-13. Instead, IL-21 is
linked to IL-2 and IL-15 and, consistent with this, a se-
quence comparison of IL-21 with IL-4, IL-15, and IL-2
indicates that IL-21 shares most sequence identity with
IL-2 (7). The Th2 locus is thought to be coordinately
regulated by adjacent gene-specific promoters and en-
hancers as well as by an intergenic regulatory element,
termed CNS, that has been shown genetically to be in-
volved in the Th2-specific regulation of the locus (23). In
addition, evidence suggests that the Th2-specific tran-
scription factor GATA-3 directly regulates IL-4, IL-5,
and IL-13 transcription and GATA-3 has also been linked
with the chromatin remodeling that occurs in the Th2 lo-
cus during Th2 differentiation (24). IL-21 expression mir-
rors the other Th2 cytokines in that it is relatively low in
activated Thp cells and high in Th2 effectors (Fig. 1).
However, we do not observe a marked preferential ex-
pression of IL-21 under Th2 skewing conditions immedi-
ately after priming like that observed for IL-4 (IL-21
mRNA-Th1   0.0004, Th2   0.0009, IL-4 mRNA-
Th1   0.0001, Th2   0.044; Fig. 1 B). One explanation
for this observation is that the CNS element may be im-
portant for the early expression of Th2 cytokines and it is
clearly not regulating IL-21 transcription. Another possi-
bility is that IL-21 transcription may be more dependent
on other Th2-specific transcription factors, such as c-maf,
which are upregulated later than GATA-3 during Th2
differentiation (25). Additionally, we have observed that
IL-21 can induce IL-21 expression in Th1 cells (unpub-
lished data). This is in contrast to the inability of IL-4 to
induce its own expression in Th1 cells, suggesting that IL-
21 expression within Th cell subsets may be more plastic
than IL-4 and subject to influences from neighboring cell
populations. It should also be noted that a previous study
on human IL-21 reported the detection of high levels of
IL-21 mRNA from freshly isolated CD4  PBLs (7). In
this study, the PBLs were not purified for naive Thps and
presumably contained effector CD4  Th2 cells poised to
express high levels of IL-21.
We demonstrate here that IL-21 inhibits STAT-4 activ-
ity by reducing STAT-4 expression. The expression of a
number of STAT proteins, including STAT-4, has been
shown to be downregulated by cytokine exposure primar-
ily through proteasome mediated degradation (26–29).
This does not appear to be the mechanism here as STAT-4
mRNA, as well as protein, is affected by IL-21 exposure
(Fig. 4 D). Several examples of regulated STAT-4 mRNA
expression have been reported. STAT-4 transcripts were
found to be preferentially expressed in Th1 cells compared
with Th2 cells (30). Moreover, the induction of STAT-4
message in maturing dendritic cells and activated macro-
phages is inhibited by exposure to the Th2 cytokines, IL-4,
and IL-10 (31). Decreased STAT-4 expression may then
in turn reinforce differentiation along the Th2 pathway.
These observations suggest that IL-21 may be in part re-
sponsible for the reduced expression of STAT-4 in Th2
cells, however STAT-4 expression is equivalent between
wild-type and IL-21R–deficient Th2 cells suggesting that
other Th2 cell cytokines can mediate this effect as well
(unpublished data).
Although we demonstrate that IL-21 compromises the
ability to signal through STAT-4, it is possible that other
STAT-4–independent pathways for IFN-  production
may also be affected by IL-21. First, the small amount of
IFN-  produced by STAT-4–deficient Th cells is also di-
minished by IL-21 exposure (unpublished data). In addi-
tion, our data suggest that T-bet expression is normal in IL-
21–treated Th1 cells. Consistent with this observation and
the recent report that T-bet targets chromatin remodeling
at the IFN-  locus, we have found that the IFN-  locus is
equally accessible to DNase 1 cleavage in both IL-21–
treated and untreated Th1 cells (reference 32 and unpub-
lished data). However, another potential IL-21 target is the
GADD45 protein family. GADD45  is preferentially ex-
pressed in Th1 cells and is able to directly activate p38 and
JNK pathways, both of which have been suggested to be
involved in IFN-  production from Th1 cells (33, 34).
Moreover, Th1 cells from GADD45 -deficient mice are
compromised in their ability to make IFN- , and like IL-
21–treated Th1 cells, produce normal amounts of TNF- 
(33). While preliminary studies do not suggest that IL-21
exposure results in gross changes in p38 and JNK activity
or GADD45  expression (unpublished data), more thor-
ough analysis in the future will be required to determine
the effect of IL-21 on these signaling pathways.
IL-21 has a unique immunosuppressive effect on IFN- 
production. Antiinflammatory cytokines, such as IL-10 and
TGF- , have been reported to have similar properties.
TGF- , like IL-21, has been reported to inhibit IFN- 
production from in vitro differentiating Th1 cells but not976 IL-21 and Th Cell Differentiation
Th1 effector cells (35). However, TGF-  treatment of Thp
cells has an even more profound immunosuppressive effect
on Th2 development compared with Th1 development,
highlighting the specificity of IL-21 action on IFN-  (35–
37). IL-10 also strongly inhibits cytokine production by T
cells, although most of these effects are thought to be indi-
rect through inhibition of APC function (5). As our studies
here were performed entirely with highly purified Thp
cells in an APC free system, the ability of IL-21 to inhibit
IFN-  production must be a direct result of this cytokine
on T cell function. Both IL-10 and TGF-  have also been
associated with the development and/or function of regu-
latory CD4  T cells which appear to inhibit a number of
inflammatory pathologies (38). It remains to be determined
if IL-21 is expressed by or involved in the development of
these regulatory cell populations.
We have demonstrated that IL-21 exhibits specific im-
munosuppressive properties on Th cells in both in vitro
and in vivo settings. However, the biological outcome of
IL-21 treatment will likely depend on the cellular context
of the signal. For example, IL-21 has been shown to pro-
mote the expansion and lytic activity of human NK cells
(7). Moreover, in contrast to what we observe in develop-
ing Th cells, IL-21 treatment of activated murine NK cells
and CD8  T cells results in enhanced IFN-  production
(12). Interestingly, whether IL-21 enhances or inhibits mu-
rine NK cell function depends largely on the activation
state of the NK cell (12). This supports our observation that
IL-21 only inhibits IFN-  production from Th1 cells dur-
ing a discrete developmental window. Taken together,
these observations suggest that the role IL-21 plays in an
ongoing immune response will likely be complex. How-
ever, the highly specific modulation of Th1 cell function
by this Th2 cytokine provides an attractive candidate for
immunomodulatory therapies.
We thank Susanne Szabo, Jyothi Rengarajan, Mike Pazin, and
Kerri Mowen for thoughtful review of the manuscript.
This work was supported by the National Institutes of Health
(NIH) grants GM 62135 and AI40171 (M.J. Grusby), AI51823
(A.R. Satoskar), an award to M.J. Grusby from the Sandler Family
Supporting Foundation and the Mathers Foundation (to M.J.
Grusby). M.J. Grusby is a scholar of the Leukemia and Lymphoma
Society.
Submitted: 17 April 2002
Revised: 14 August 2002
Accepted: 19 August 2002
References
1. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional
diversity of helper T lymphocytes. Nature. 383:787–793.
2. Glimcher, L.H., and K.M. Murphy. 2000. Lineage commit-
ment in the immune system: the T helper lymphocyte grows
up. Genes Dev. 14:1693–1711.
3. O’Garra, A. 1998. Cytokines induce the development of
functionally heterogeneous T helper cell subsets. Immunity.
8:275–283.
4. Maggi, E., P. Parronchi, R. Manetti, C. Simonelli, M.P. Pic-
cinni, F.S. Rugiu, M. De Carli, M. Ricci, and S. Romag-
nani. 1992. Reciprocal regulatory effects of IFN-  and IL-4
on the in vitro development of human Th1 and Th2 clones.
J. Immunol. 148:2142–2147.
5. Moore, K.W., R. de Waal Malefyt, R.L. Coffman, and A.
O’Garra. 2001. Interleukin-10 and the interleukin-10 recep-
tor. Annu. Rev. Immunol. 19:683–765.
6. Fitch, F.W., M.D. McKisic, D.W. Lancki, and T.F. Gajew-
ski. 1993. Differential regulation of murine T lymphocyte
subsets. Annu. Rev. Immunol. 11:29–48.
7. Parrish-Novak, J., S.R. Dillon, A. Nelson, A. Hammond, C.
Sprecher, J.A. Gross, J. Johnston, K. Madden, W. Xu, J.
West, et al. 2000. Interleukin 21 and its receptor are involved
in NK cell expansion and regulation of lymphocyte function.
Nature. 408:57–63.
8. Vosshenrich, C.A., and J.P. Di Santo. 2001. Cytokines: IL-
21 joins the  (c)-dependent network? Curr. Biol. 11:R175–
R177.
9. Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D.
Foster, and K. Sugamura. 2001. Cutting edge: the common
 -chain is an indispensable subunit of the IL-21 receptor
complex. J. Immunol. 167:1–5.
10. Ozaki, K., K. Kikly, D. Michalovich, P.R. Young, and W.J.
Leonard. 2000. Cloning of a type I cytokine receptor most
related to the IL-2 receptor   chain. Proc. Natl. Acad. Sci.
USA. 97:11439–11444.
11. Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby.
1996. Stat6 is required for mediating responses to IL-4 and
for development of Th2 cells. Immunity. 4:313–319.
12. Kasaian, M.T., M.J. Whitters, L.L. Carter, L.D. Lowe, J.M.
Jussif, B. Deng, K.A. Johnson, J.S. Witek, M. Senices, R.F.
Konz, et al. 2002. IL-21 limits NK cell responses and pro-
motes antigen-specific T cell activation: a mediator of the
transition from innate to adaptive immunity. Immunity. 16:
559–569.
13. Szabo, S.J., S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman,
and L.H. Glimcher. 2000. A novel transcription factor, T-bet,
directs Th1 lineage commitment. Cell. 100:655–669.
14. Bird, J.J., D.R. Brown, A.C. Mullen, N.H. Moskowitz,
M.A. Mahowald, J.R. Sider, T.F. Gajewski, C.R. Wang, and
S.L. Reiner. 1998. Helper T cell differentiation is controlled
by the cell cycle. Immunity. 9:229–237.
15. Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999.
Quantification of murine cytokine mRNAs using real time
quantitative reverse transcriptase PCR. Cytokine. 11:305–
312.
16. Szabo, S.J., B.M. Sullivan, C. Stemmann, A.R. Satoskar,
B.P. Sleckman, and L.H. Glimcher. 2002. Distinct effects of
T-bet in TH1 lineage commitment and IFN-  production in
CD4 and CD8 T cells. Science. 295:338–342.
17. Reiner, S.L., and R.M. Locksley. 1995. The regulation of
immunity to Leishmania major. Annu. Rev. Immunol. 13:
151–177.
18. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami,
S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto,
and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling.
Nature. 380:627–630.
19. Shimoda, K., J. van Deursen, M.Y. Sangster, S.R. Sarawar,
R.T. Carson, R.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka,
D.A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response
and IgE class switching in mice with disrupted Stat6 gene.
Nature. 380:630–633.
20. Wu, C., J. Ferrante, M.K. Gately, and J. Magram. 1997.977 Wurster et al.
Characterization of IL-12 receptor  1 chain (IL-12R 1)-
deficient mice: IL-12R 1 is an essential component of the
functional mouse IL-12 receptor. J. Immunol. 159:1658–
1665.
21. Szabo, S.J., A.S. Dighe, U. Gubler, and K.M. Murphy. 1997.
Regulation of the interleukin (IL)-12R  2 subunit expres-
sion in developing T helper 1 (Th1) and Th2 cells. J. Exp.
Med. 185:817–824.
22. Wurster, A.L., T. Tanaka, and M.J. Grusby. 2000. The biol-
ogy of Stat4 and Stat6. Oncogene. 19:2577–2584.
23. Mohrs, M., C.M. Blankespoor, Z.E. Wang, G.G. Loots, V.
Afzal, H. Hadeiba, K. Shinkai, E.M. Rubin, and R.M. Locks-
ley. 2001. Deletion of a coordinate regulator of type 2 cyto-
kine expression in mice. Nat. Immunol. 2:842–847.
24. Ouyang, W., M. Lohning, Z. Gao, M. Assenmacher, S.
Ranganath, A. Radbruch, and K.M. Murphy. 2000. Stat6-
independent GATA-3 autoactivation directs IL-4-indepen-
dent Th2 development and commitment. Immunity. 12:27–
37.
25. Ho, I.C., M.R. Hodge, J.W. Rooney, and L.H. Glimcher.
1996. The proto-oncogene c-maf is responsible for tissue-
specific expression of interleukin-4. Cell. 85:973–983.
26. Kim, T.K., and T. Maniatis. 1996. Regulation of interferon-
 -activated STAT1 by the ubiquitin-proteasome pathway.
Science. 273:1717–1719.
27. Rayanade, R.J., K. Patel, M. Ndubuisi, S. Sharma, S.
Omura, J.D. Etlinger, R. Pine, and P.B. Sehgal. 1997. Pro-
teasome- and p53-dependent masking of signal transducer
and activator of transcription (STAT) factors. J. Biol. Chem.
272:4659–4662.
28. Wang, K.S., E. Zorn, and J. Ritz. 2001. Specific down-regu-
lation of interleukin-12 signaling through induction of phos-
pho-STAT4 protein degradation. Blood. 97:3860–3866.
29. Yu, C.L., and S.J. Burakoff. 1997. Involvement of protea-
somes in regulating Jak-STAT pathways upon interleukin-2
stimulation. J. Biol. Chem. 272:14017–14020.
30. Chtanova, T., R.A. Kemp, A.P. Sutherland, F. Ronchese,
and C.R. Mackay. 2001. Gene microarrays reveal extensive
differential gene expression in both CD4+ and CD8+ type 1
and type 2 T cells. J. Immunol. 167:3057–3063.
31. Fukao, T., D.M. Frucht, G. Yap, M. Gadina, J.J. O’Shea, and
S. Koyasu. 2001. Inducible expression of Stat4 in dendritic
cells and macrophages and its critical role in innate and adap-
tive immune responses. J. Immunol. 166:4446–4455.
32. Mullen, A.C., F.A. High, A.S. Hutchins, H.W. Lee, A.V.
Villarino, D.M. Livingston, A.L. Kung, N. Cereb, T.P. Yao,
S.Y. Yang, and S.L. Reiner. 2001. Role of T-bet in commit-
ment of TH1 cells before IL-12-dependent selection. Science.
292:1907–1910.
33. Lu, B., H. Yu, C. Chow, B. Li, W. Zheng, R.J. Davis, and
R.A. Flavell. 2001. GADD45  mediates the activation of the
p38 and JNK MAP kinase pathways and cytokine production
in effector TH1 cells. Immunity. 14:583–590.
34. Yang, J., H. Zhu, T.L. Murphy, W. Ouyang, and K.M.
Murphy. 2001. IL-18-stimulated GADD45  required in cy-
tokine-induced, but not TCR-induced, IFN-  production.
Nat. Immunol. 2:157–164.
35. Ludviksson, B.R., D. Seegers, A.S. Resnick, and W. Strober.
2000. The effect of TGF- 1 on immune responses of naive
versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol. 30:
2101–2111.
36. Heath, V.L., E.E. Murphy, C. Crain, M.G. Tomlinson, and
A. O’Garra. 2000. TGF- 1 down-regulates Th2 develop-
ment and results in decreased IL-4-induced STAT6 activa-
tion and GATA-3 expression. Eur. J. Immunol. 30:2639–
2649.
37. Gorelik, L., P.E. Fields, and R.A. Flavell. 2000. Cutting
edge: TGF-  inhibits Th type 2 development through inhi-
bition of GATA-3 expression. J. Immunol. 165:4773–4777.
38. Read, S., and F. Powrie. 2001. CD4+ regulatory T cells.
Curr. Opin. Immunol. 13:644–649.